Pulmonary Arterial Hypertension Trials in santa barbara, united states
Conditions / Pulmonary Arterial Hypertension / santa barbara, united states
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04273945 | Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04811092 | Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) | COMPLETED | PHASE3 |
| NCT03197688 | Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States | COMPLETED | — |
| NCT03278002 | A Registry for Patients Taking Uptravi | COMPLETED | — |
| NCT02126943 | OPsumit USers Registry | COMPLETED | — |
| NCT04796337 | A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | PHASE3 |
| NCT00667823 | Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT00660179 | Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |